Literature DB >> 7039316

Perinatal group B streptococcal colonization and infection.

J G Allardice, T F Baskett, M M Seshia, N Bowman, R Malazdrewicz.   

Abstract

Of 2,169 patients screened in labor for vaginal group B streptococcal colonization, 164 (7.6%) had positive results. Five hundred twenty-four of the patients were screened in the antenatal period, and 57 patients with positive tests for group B streptococcus were treated in labor with intravenous ampicillin. Four of the treatment group gave birth to colonized infants but none became infected. Of the 136 untreated mother-infant pairs with positive tests, 62 neonates were colonized, nine became infected, and three died. In the presence of an attack rate of 6.6% among infants born to colonized mothers, antenatal screening and treatment in labor of mothers colonized with group B streptococcus will reduce neonatal colonization and infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7039316     DOI: 10.1016/s0002-9378(16)32429-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  24 in total

1.  Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions.

Authors:  H D Davies; C E Adair; A Schuchat; D E Low; R S Sauve; A McGeer
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

2.  Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  CMAJ       Date:  2002-04-02       Impact factor: 8.262

3.  Prevention of group B streptococcal infection in newborns. Recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors: 
Journal:  Can Fam Physician       Date:  2002-05       Impact factor: 3.275

4.  The prevention of early-onset group B streptococcal infections in the newborn.

Authors: 
Journal:  Can J Infect Dis       Date:  1994-11

5.  Preventing group B streptococcal infections: new recommendations.

Authors:  H Dele Davies
Journal:  Can J Infect Dis       Date:  2002-07

Review 6.  Molecular-based screening for perinatal group B streptococcal infection: implications for prevention and therapy.

Authors:  Stéphane Emonet; Jacques Schrenzel; Begoña Martinez de Tejada
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

7.  Preventing group B streptococcal infections: New recommendations.

Authors:  H Dele Davies
Journal:  Paediatr Child Health       Date:  2002-07       Impact factor: 2.253

8.  Enhanced Postnatal Acquisition of Hypervirulent Group B Streptococcus.

Authors:  Adam J Ratner
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

9.  Prevalence and significance of group B Streptococcus in a large obstetric population.

Authors:  A K Joshi; C I Chen; R W Turnell
Journal:  CMAJ       Date:  1987-08-01       Impact factor: 8.262

10.  Cost-effectiveness of universal prophylaxis in pregnancy with prior group B streptococci colonization.

Authors:  Mark A Turrentine; Mildred M Ramirez; Joan M Mastrobattista
Journal:  Infect Dis Obstet Gynecol       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.